Research graph
References from Postprocedural risk in C1-inhibitor–deficient hereditary angioedema (HAE-C1INH). Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.anai.2026.05.030
10.1016/j.anai.2026.05.030 · External reference
Updates on the current and evolving treatment for hereditary angioedema
10.1016/j.jaip.2025.11.039 · 2026 · External reference
The international WAO/EAACI guideline for the management of hereditary angioedema-the 2021 revision and update
10.1111/all.15214 · 2022 · External reference
Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: findings from an international patient registry
10.1016/j.anai.2016.10.006 · 2017 · External reference
International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency
10.1016/j.jaci.2011.11.025 · 2012 · External reference
US HAEA medical advisory board 2020 guidelines for the management of hereditary angioedema
10.1016/j.jaip.2020.08.046 · 2021 · External reference
